Viatris Gross Profit 2010-2024 | VTRS

Viatris annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Viatris gross profit for the quarter ending June 30, 2024 was $1.445B, a 10.15% decline year-over-year.
  • Viatris gross profit for the twelve months ending June 30, 2024 was $6.237B, a 1.04% increase year-over-year.
  • Viatris annual gross profit for 2023 was $6.439B, a 0.9% decline from 2022.
  • Viatris annual gross profit for 2022 was $6.497B, a 16.53% increase from 2021.
  • Viatris annual gross profit for 2021 was $5.576B, a 46.85% increase from 2020.
Viatris Annual Gross Profit
(Millions of US $)
2023 $6,439
2022 $6,497
2021 $5,576
2020 $3,797
2019 $3,898
2018 $4,002
2017 $4,783
2016 $4,697
2015 $4,216
2014 $3,528
2013 $3,040
2012 $2,908
2011 $2,563
2010 $2,217
2009 $2,074
Viatris Quarterly Gross Profit
(Millions of US $)
2024-06-30 $1,445
2024-03-31 $1,504
2023-12-31 $1,597
2023-09-30 $1,691
2023-06-30 $1,609
2023-03-31 $1,542
2022-12-31 $1,274
2022-09-30 $1,748
2022-06-30 $1,703
2022-03-31 $1,771
2021-12-31 $1,546
2021-09-30 $1,574
2021-06-30 $1,328
2021-03-31 $1,127
2020-12-31 $706
2020-09-30 $1,159
2020-06-30 $1,026
2020-03-31 $906
2019-12-31 $1,087
2019-09-30 $1,072
2019-06-30 $933
2019-03-31 $805
2018-12-31 $1,016
2018-09-30 $1,039
2018-06-30 $963
2018-03-31 $984
2017-12-31 $1,295
2017-09-30 $1,178
2017-06-30 $1,225
2017-03-31 $1,085
2016-12-31 $1,335
2016-09-30 $1,283
2016-06-30 $1,172
2016-03-31 $907
2015-12-31 $1,063
2015-09-30 $1,315
2015-06-30 $1,008
2015-03-31 $830
2014-12-31 $969
2014-09-30 $1,012
2014-06-30 $809
2014-03-31 $738
2013-12-31 $796
2013-09-30 $809
2013-06-30 $742
2013-03-31 $694
2012-12-31 $742
2012-09-30 $793
2012-06-30 $703
2012-03-31 $670
2011-12-31 $645
2011-09-30 $658
2011-06-30 $669
2011-03-31 $591
2010-12-31 $579
2010-09-30 $580
2010-06-30 $542
2010-03-31 $516
2009-12-31 $516
2009-09-30 $505
2009-06-30 $528
2009-03-31 $526
Sector Industry Market Cap Revenue
Medical Medical Services $13.858B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00